Pharmaceutical Technology Europe
One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.
Gerallt Williams
Advertisement
Gerallt Williams is Director, R&D Laboratory Services at AptarGroup SAS, France.
Articles by Gerallt Williams
Advertisement
Latest Updated Articles
Understanding The Requirements For Effective Nasal Drug DeliverySeptember 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5